Literature DB >> 18328902

Delayed allergic reactions to omalizumab: are patients reporting all cases?

Peter J Barry, Ann O'Mahony, Collette Finnegan, Terence M O'Connor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18328902     DOI： 10.1016/j.jaci.2007.12.1184

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  3 in total

Review 1.  Asthma that is unresponsive to usual care.

Authors:  Kenneth R Chapman; Andrew McIvor
Journal:  CMAJ       Date:  2009-10-13       Impact factor: 8.262

Review 2.  Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2008.

Authors:  Andrea J Apter
Journal:  J Allergy Clin Immunol       Date:  2009-01       Impact factor: 10.793

3.  Omalizumab: Practical considerations regarding the risk of anaphylaxis.

Authors:  Harold L Kim; Richard Leigh; Allan Becker
Journal:  Allergy Asthma Clin Immunol       Date:  2010-12-03       Impact factor: 3.406
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.